News | SummitMD

4 Takeaways from the 2021 ESC/EACTS Guideline for Valvular Heart Disease

New updates include timing of intervention, TAVR vs. SAVR selection criteria, surgery priority over TEER for MR, and anticoagulation strategies for VHD subgroups

News | SummitMD

Rushing Angiography for OHCA Patients without ST-Segment Elevation Largely Unbeneficial

TOMAHAWK investigators stress importance of selective and thorough process for angio for better outcomes

News | SummitMD

Edoxaban Trial Paints Fragmented Picture for Doacs in AF-TAVR: ENVISAGE-TAVI AF

Edoxaban noninferior to VKA for adverse events but carries higher bleeding risk

News | SummitMD

1-Month DAPT in High-Bleeding Risk Noninferior for Ischemic Outcomes, Less Bleeding: MASTER-DAPT

In HBR patients after DES-PCI, shorter 1-month DAPT showed noninferior NACE/MACCE rates with less major bleeds compared to 12-month DAPT

News | AP VALVES & SH 2021 Virtual

MITRA-FR vs. COAPT: Conflicting Results Harmonize to Deduce Ideal HF-FMR Patient for MitraClip

[AP VALVES & SH 2021] Insights gleaned from opposing MitraClip results help define optimal anatomical features for TEER

News | AP VALVES & SH 2021 Virtual

Data Hints at TAVR Expansion Into Low-risk Bicuspid AS but RCTs on Risky Morphology Still Missing

[AP VALVES & SH 2021] Cardiologists call for randomized trials defining morphology for positive TAVR outcomes in low surgical risk patients with bicuspid aortic stenosis

News | AP VALVES & SH 2021 Virtual

4 Upcoming and Novel LAAO Devices and Best Multimodal Imaging for Challenging Cases

[AP VALVES & SH 2021] Philippe Garot, MD looks at pre-clinical devices touted to help positioning/sizing and mitigate LAAO procedure risk with complex anatomy